|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Interest-earning deposits with banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Securities available for sale, at fair value | ||||||||||||||||||||
| Securities held to maturity (fair value of $21,903 at September 30, 2023; and $21,744 at June 30, 2023) | ||||||||||||||||||||
| Securities held to maturity, net of allowance for credit losses of $486 at June 30, 2026 and $452 at December 31, 2025 (fair value of $43,826 at June 30, 2026 and $40,175 at December 31, 2025) | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Federal Home Loan Bank of New York stock | ||||||||||||||||||||
| Trading securities, at fair value | ||||||||||||||||||||
| Federal Reserve Bank of New York and Federal Home Loan Bank of New York stock | ||||||||||||||||||||
| Loans receivable | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Net loans receivable | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest bearing deposits | ||||||||||||||||||||
| Interest bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Mortgagors' escrow deposits | ||||||||||||||||||||
| Borrowings from Federal Home Loan Bank of New York | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common stock ($0.01 par value, 75,000,000 shares authorized 24,841,663 and 25,072,214 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Unallocated common stock of Employee Stock Ownership Plan ("ESOP") | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
